Point-of-care testing at the disaster-emergency-critical care interface

Nam Tran, Zachary Godwin, Jennifer Bockhold, Gerald J Kost

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Point-of-care testing allows for medical testing to be performed across the disaster-emergency-critical care continuum. The disaster-emergency-critical care continuum begins with the identification of at-risk patients, followed by patient stabilization, and ultimately transfer to an alternate care facility or mobile hospital for comprehensive critical care. Gaps at the interfaces for each of these settings lead to excess mortality and morbidity. Disaster victims are at risk for acute myocardial infarctions, acute kidney injury (AKI), and sepsis. However, cardiac biomarker testing, renal function testing, and multiplex rapid pathogen detection are often unavailable or inadequate during disasters. Cardiac biomarker reagents require refrigeration; traditional renal function tests (ie, serum creatinine) exhibit poor sensitivity for predicting AKI in critically ill patients, and culture-based pathogen detection is too slow to help initiate early-directed antimicrobial therapy. We propose 3 value propositions detailing how rapid, point-of-care, and environmentally hardened cardiac biomarker, AKI, and multiplex pathogen testing harmonize the interface between disaster, emergency, and critical care.

Original languageEnglish (US)
Pages (from-to)180-183
Number of pages4
JournalPoint of Care
Volume11
Issue number4
DOIs
StatePublished - Dec 2012

Fingerprint

Emergency Medical Services
Disasters
Critical Care
Acute Kidney Injury
Biomarkers
Disaster Victims
Point-of-Care Systems
Mobile Health Units
Kidney
Refrigeration
Critical Illness
Creatinine
Sepsis
Myocardial Infarction
Morbidity
Mortality
Point-of-Care Testing
Serum
Therapeutics

Keywords

  • acute kidney injury
  • acute myocardial infarction
  • biomarker
  • cardiac biomarker
  • crush injury
  • neutrophil gelatinase-associated lipocalin
  • pathogen detection
  • robustness
  • sepsis
  • turnaround time

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Point-of-care testing at the disaster-emergency-critical care interface. / Tran, Nam; Godwin, Zachary; Bockhold, Jennifer; Kost, Gerald J.

In: Point of Care, Vol. 11, No. 4, 12.2012, p. 180-183.

Research output: Contribution to journalArticle

Tran, Nam ; Godwin, Zachary ; Bockhold, Jennifer ; Kost, Gerald J. / Point-of-care testing at the disaster-emergency-critical care interface. In: Point of Care. 2012 ; Vol. 11, No. 4. pp. 180-183.
@article{bbd56267e2e3488b949b7d014b062c79,
title = "Point-of-care testing at the disaster-emergency-critical care interface",
abstract = "Point-of-care testing allows for medical testing to be performed across the disaster-emergency-critical care continuum. The disaster-emergency-critical care continuum begins with the identification of at-risk patients, followed by patient stabilization, and ultimately transfer to an alternate care facility or mobile hospital for comprehensive critical care. Gaps at the interfaces for each of these settings lead to excess mortality and morbidity. Disaster victims are at risk for acute myocardial infarctions, acute kidney injury (AKI), and sepsis. However, cardiac biomarker testing, renal function testing, and multiplex rapid pathogen detection are often unavailable or inadequate during disasters. Cardiac biomarker reagents require refrigeration; traditional renal function tests (ie, serum creatinine) exhibit poor sensitivity for predicting AKI in critically ill patients, and culture-based pathogen detection is too slow to help initiate early-directed antimicrobial therapy. We propose 3 value propositions detailing how rapid, point-of-care, and environmentally hardened cardiac biomarker, AKI, and multiplex pathogen testing harmonize the interface between disaster, emergency, and critical care.",
keywords = "acute kidney injury, acute myocardial infarction, biomarker, cardiac biomarker, crush injury, neutrophil gelatinase-associated lipocalin, pathogen detection, robustness, sepsis, turnaround time",
author = "Nam Tran and Zachary Godwin and Jennifer Bockhold and Kost, {Gerald J}",
year = "2012",
month = "12",
doi = "10.1097/POC.0b013e318265f7d9",
language = "English (US)",
volume = "11",
pages = "180--183",
journal = "Point of Care",
issn = "1533-029X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Point-of-care testing at the disaster-emergency-critical care interface

AU - Tran, Nam

AU - Godwin, Zachary

AU - Bockhold, Jennifer

AU - Kost, Gerald J

PY - 2012/12

Y1 - 2012/12

N2 - Point-of-care testing allows for medical testing to be performed across the disaster-emergency-critical care continuum. The disaster-emergency-critical care continuum begins with the identification of at-risk patients, followed by patient stabilization, and ultimately transfer to an alternate care facility or mobile hospital for comprehensive critical care. Gaps at the interfaces for each of these settings lead to excess mortality and morbidity. Disaster victims are at risk for acute myocardial infarctions, acute kidney injury (AKI), and sepsis. However, cardiac biomarker testing, renal function testing, and multiplex rapid pathogen detection are often unavailable or inadequate during disasters. Cardiac biomarker reagents require refrigeration; traditional renal function tests (ie, serum creatinine) exhibit poor sensitivity for predicting AKI in critically ill patients, and culture-based pathogen detection is too slow to help initiate early-directed antimicrobial therapy. We propose 3 value propositions detailing how rapid, point-of-care, and environmentally hardened cardiac biomarker, AKI, and multiplex pathogen testing harmonize the interface between disaster, emergency, and critical care.

AB - Point-of-care testing allows for medical testing to be performed across the disaster-emergency-critical care continuum. The disaster-emergency-critical care continuum begins with the identification of at-risk patients, followed by patient stabilization, and ultimately transfer to an alternate care facility or mobile hospital for comprehensive critical care. Gaps at the interfaces for each of these settings lead to excess mortality and morbidity. Disaster victims are at risk for acute myocardial infarctions, acute kidney injury (AKI), and sepsis. However, cardiac biomarker testing, renal function testing, and multiplex rapid pathogen detection are often unavailable or inadequate during disasters. Cardiac biomarker reagents require refrigeration; traditional renal function tests (ie, serum creatinine) exhibit poor sensitivity for predicting AKI in critically ill patients, and culture-based pathogen detection is too slow to help initiate early-directed antimicrobial therapy. We propose 3 value propositions detailing how rapid, point-of-care, and environmentally hardened cardiac biomarker, AKI, and multiplex pathogen testing harmonize the interface between disaster, emergency, and critical care.

KW - acute kidney injury

KW - acute myocardial infarction

KW - biomarker

KW - cardiac biomarker

KW - crush injury

KW - neutrophil gelatinase-associated lipocalin

KW - pathogen detection

KW - robustness

KW - sepsis

KW - turnaround time

UR - http://www.scopus.com/inward/record.url?scp=84870445589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870445589&partnerID=8YFLogxK

U2 - 10.1097/POC.0b013e318265f7d9

DO - 10.1097/POC.0b013e318265f7d9

M3 - Article

AN - SCOPUS:84870445589

VL - 11

SP - 180

EP - 183

JO - Point of Care

JF - Point of Care

SN - 1533-029X

IS - 4

ER -